72 related articles for article (PubMed ID: 12442639)
1. Study on the usefulness of seratrodast in the treatment of chronic pulmonary emphysema.
Horiguchi T; Tachikawa S; Kondo R; Shiga M; Hirose M; Fukumoto K
Arzneimittelforschung; 2002; 52(10):764-8. PubMed ID: 12442639
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
Muramatsu H; Kotajima R; Sato T
Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
[TBL] [Abstract][Full Text] [Related]
3. Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients?
Tanaka H; Igarashi T; Saitoh T; Teramoto S; Miyazaki N; Kaneko S; Ohmichi M; Abe S
Respir Med; 1999 Dec; 93(12):891-7. PubMed ID: 10653051
[TBL] [Abstract][Full Text] [Related]
4. The effect of seratrodast on eosinophil cationic protein and symptoms in asthmatics.
Fukuoka T; Miyake S; Umino T; Inase N; Tojo N; Yoshizawa Y
J Asthma; 2003 May; 40(3):257-64. PubMed ID: 12807169
[TBL] [Abstract][Full Text] [Related]
5. [The role of platelet activation in the pathogenesis of asthma].
Heng W; Wang G; Wang Z
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):343-6. PubMed ID: 11778515
[TBL] [Abstract][Full Text] [Related]
6. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
Yetkin O; Gunen H
Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
[TBL] [Abstract][Full Text] [Related]
7. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S
Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and physiological features of chronic pulmonary emphysema with paroxysmal dyspnea attacks masquerading as bronchial asthma--improvement of respiratory function after combination therapy of intravenous aminophylline and subcutaneous epinephrine following daily oral administration of prednisolone].
Toda M; Motojima S; Fukuda T; Makino S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Apr; 29(4):460-8. PubMed ID: 1865598
[TBL] [Abstract][Full Text] [Related]
9. [Effects of oxitropium bromide on exercise and lung function in patients with pulmonary emphysema].
Nakanishi N; Ueda N; Kitade M; Moritaka T; Kamei T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):38-42. PubMed ID: 9071154
[TBL] [Abstract][Full Text] [Related]
10. Blocking of thromboxane A₂ receptor attenuates airway mucus hyperproduction induced by cigarette smoke.
An J; Li JQ; Wang T; Li XO; Guo LL; Wan C; Liao ZL; Dong JJ; Xu D; Wen FQ
Eur J Pharmacol; 2013 Mar; 703(1-3):11-7. PubMed ID: 23399768
[TBL] [Abstract][Full Text] [Related]
11. Population analysis of the pharmacokinetics and pharmacodynamics of seratrodast in patients with mild to moderate asthma.
Samara E; Cao G; Locke C; Granneman GR; Dean R; Killian A
Clin Pharmacol Ther; 1997 Oct; 62(4):426-35. PubMed ID: 9357394
[TBL] [Abstract][Full Text] [Related]
12. [Value of orally administered retard morphine for therapy of severe pulmonary emphysema of the pink-puffer type. A pilot study].
Schönhofer B; Köhler D
Dtsch Med Wochenschr; 1998 Nov; 123(48):1433-8. PubMed ID: 9858950
[TBL] [Abstract][Full Text] [Related]
13. Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.
Aizawa H; Inoue H; Nakano H; Matsumoto K; Yoshida M; Fukuyama S; Koto H; Hara N
Prostaglandins Leukot Essent Fatty Acids; 1998 Sep; 59(3):185-90. PubMed ID: 9844991
[TBL] [Abstract][Full Text] [Related]
14. Effect of preceding inspiratory speed and end-inspiratory pause on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients.
Boni E; Chiari S; Trigiani M; Gatta D; Pini L; Tantucci C
Respiration; 2009; 78(3):270-7. PubMed ID: 19299889
[TBL] [Abstract][Full Text] [Related]
15. [Effect of lung transplantation on pulmonary function in 5 patients with chronic obstructive pulmonary disease].
Liu JM; Yang WL; Jiang GN; Ding JA; Wang YM; Zheng W; Zhu D; Gao BL; Jiang P; Wu W
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Aug; 28(8):509-12. PubMed ID: 16207394
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of the beta2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Clinical study with special reference to health-related quality of life and activities of daily living.
Shioya T; Satake M; Sato K; Sano MA; Sugawara K; Takahashi H; Honma M
Arzneimittelforschung; 2008; 58(1):24-8. PubMed ID: 18368947
[TBL] [Abstract][Full Text] [Related]
17. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
18. CT and functional respiratory tests. Evaluation of efficacy of bronchodilator therapy in chronic obstructive pulmonary disease (COPD).
Costantini AM; Sallustio G; Misciasci T; Corbo GM; Valente S; Pirronti T; Marano P
Radiol Med; 2004; 108(1-2):17-27. PubMed ID: 15269687
[TBL] [Abstract][Full Text] [Related]
19. [The effect of bronchodilators in aerosol form on pulmonary function in patients with pulmonary emphysema].
Bosnjak-Petrović V; Radovanović S
Plucne Bolesti; 1989; 41(1-2):72-4. PubMed ID: 2798578
[TBL] [Abstract][Full Text] [Related]
20. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
